Clinical Trial: All About Youth: Evaluation of Sexual Risk Avoidance and Risk Reduction Programs for Middle School Students

This study is not yet open for patient recruitment.
Verified by The University of Texas Health Science Center, Houston September 2005

Sponsors and Collaborators: The University of Texas Health Science Center, Houston
Centers for Disease Control and Prevention
Information provided by: The University of Texas Health Science Center, Houston
ClinicalTrials.gov Identifier: NCT00167505

Purpose

This study will evaluate the efficacy of two curricula relative to standard care. The first is a sexual risk avoidance curriculum for middle school students that includes abstinence until marriage and complies with Title V Section 510 A-H abstinence education requirements. The second is a sexual risk reduction curriculum for middle school students that includes abstinence and condom/contraceptive information and skills. Each intervention will consist of an age-appropriate classroom curriculum and a CD-ROM-based tailored intervention delivered in 7th and 8th grade. The overall goal of the study is to identify common elements of effective sexuality education curricula that will be of benefit to youth.
Condition Intervention
Human Immunodeficiency Virus
Sexually Transmitted Diseases
Pregnancy
 Behavior: Sexual Risk Avoidance
 Behavior: Sexual Risk Reduction

MedlinePlus related topics:  Sexually Transmitted Diseases

Study Type: Interventional
Study Design: Prevention, Randomized, Open Label, Active Control, Parallel Assignment, Efficacy Study

Official Title: SIP 4-04 Evaluation of Abstinence-Only and Abstinence-Plus Program to Prevent HIV, STD, and Pregnancy Among Middle School Students

Further Study Details: 
Primary Outcomes: delay onset of sex; reduce the proportion of sexually active
Secondary Outcomes: knowledge; skills; self-efficacy; attitudes; condom use; alcohol/drug use; number of sexual partners
Expected Total Enrollment:  1500

Study start: September 2006;  Expected completion: September 2009
Last follow-up: May 2009;  Data entry closure: August 2009

This study will evaluate the efficacy of two curricula relative to standard care. The first is a sexual risk avoidance curriculum for middle school students that includes abstinence until marriage and complies with Title V Section 510 A-H abstinence education requirements. The second is a sexual risk reduction curriculum for middle school students that includes abstinence and condom/contraceptive information and skills. Each intervention will consist of an age-appropriate classroom curriculum and a CD-ROM-based tailored intervention delivered in 7th and 8th grade. The overall goal of the study is to identify common elements of effective sexuality education curricula that will be of benefit to youth. The study design will be a randomized controlled trial conducted in fifteen inner-city middle schools in Houston, Texas. Five schools will be randomly assigned to a sexual risk avoidance intervention, five to a sexual risk reduction intervention, and five to a comparison (standard care) condition. Approximately, 1,500 7th grade students will be recruited into the study and will be followed over a two-year period. Study outcomes will include sexual risk behaviors, substance use behaviors, intentions, perceived risk associated with sexual and substance use, knowledge, self-efficacy, attitudes, perceived norms, perceived parental values, parental monitoring, and parent-child communication.

Eligibility

Ages Eligible for Study:  11 Years   -   16 Years,  Genders Eligible for Study:  Both

Accepts Healthy Volunteers

Criteria

Inclusion Criteria:

  • 7th graders attending regular classes in Houston Independent School District middle schools

Exclusion Criteria:

  • No students will be excluded based on race/ethnicity, age, or gender.
  • Students will be informed that the surveys and intervention materials will only be available in English and will be asked to consider their comfort level with participating in the study.

Location and Contact Information

Please refer to this study by ClinicalTrials.gov identifier  NCT00167505

Melanie A Thiel, BA      713-500-9645    Melanie.A.Thiel@uth.tmc.edu
Kiara K Spooner, DrPH      713-500-9682    Kiara.K.Spooner@uth.tmc.edu

Texas
      University of Texas Houston School of Public Health, Houston,  Texas,  77030,  United States
Melanie A Thiel, BA  713-500-9645    Melanie.A.Thiel@uth.tmc.edu 
Kiara K Spooner, DrPH  713-500-9682    Kiara.K.Spooner@uth.tmc.edu 
Christine Markham, PhD,  Principal Investigator

Study chairs or principal investigators

Christine Markham, PhD,  Principal Investigator,  University of Texas Houston School of Public Health   

More Information

Study ID Numbers:  U48/DP000057
Last Updated:  September 13, 2005
Record first received:  September 9, 2005
ClinicalTrials.gov Identifier:  NCT00167505
Health Authority: United States: Institutional Review Board
ClinicalTrials.gov processed this record on 2005-09-20



Common Treatments

[ Disclaimer: The information on GoldBamboo for any particular treatment, medicine, drug, or herbal product might be missing or incomplete, and should never be used as a single source of knowledge. GoldBamboo generally has links to authoritative sites displayed toward the bottom of each topic page under the heading "Resources". ]

Follow Us